Insulet (PODD)

• Market cap: $9.15B
• 1 day: -2.02%
• 5 days: -11.63%
• 1 month: -8.8%
• 3 months: -11.55%
• 6 months: -44.74%
• Year to date: -53.36%
• 1 year: -60.95%
• 5 years: -55.28%
• 10 years: 215.24%
• Sector: Healthcare
• Industry: Medical Devices

About: Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, more than 600,000 insulin-dependent diabetic patients are using it worldwide.

Employees: 5,400